Enliven Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $517k | 37k | 13.84 |
| 2023-09-30 | $469k | 34k | 13.66 |
| 2023-06-30 | $710k | 35k | 20.41 |